BioAtla, Inc. (BCAB) Revenue (2020 - 2025)

BioAtla (BCAB) has reported Revenue for 4 consecutive years, with $2.0 million the latest figure, recorded in Q4 2025.

• Revenue for Q4 2025 came in at $2.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $13.0 million (up 18.18% YoY), and the FY2025 annual result was $2.0 million, down 81.82% from the prior year.
• Revenue was $2.0 million for Q4 2025 at BioAtla, down from $11.0 million in the prior quarter.
• Over five years, Revenue peaked at $11.0 million in Q3 2024 and troughed at $250000.0 in Q2 2021.
• Average Revenue over 3 years is $4.4 million, with a median of $2.0 million recorded in 2025.
• The widest YoY moves for Revenue: up 31.58% in 2021, down 31.58% in 2021.
• Over 3 years, Revenue stood at $250000.0 in 2021, then soared by 4300.0% to $11.0 million in 2024, then sank by 81.82% to $2.0 million in 2025.
• Per Business Quant data, the three most recent Revenue figures were $2.0 million in Q4 2025, $11.0 million in Q3 2024, and $250000.0 in Q2 2021.